Analyst Ratings For NASDAQ:DXCM – Dexcom (NASDAQ:DXCM)
Today, NASDAQ:DXCM – Dexcom (NASDAQ:DXCM) stock received an upgrade by JPMorgan Chase & Co. from Neutral ➝ Overweight with a price target of $80.00 ➝ $115.00.
Some recent analyst ratings include
- 6/8/2018-JPMorgan Chase & Co. Upgrade from a “Neutral ➝ Overweight” rating to a “” rating.
- 5/11/2018-Bank of America initiated coverage with a Buy ➝ Buy rating.
- 5/3/2018-BTIG Research Reiterated Rating of Hold.
- On 5/23/2018 Richard Doubleday, EVP, sold 2,581 with an average share price of $86.00 per share and the total transaction amounting to $221,966.00.
- On 5/15/2018 Terrance H Gregg, Insider, sold 10,000 with an average share price of $85.90 per share and the total transaction amounting to $859,000.00.
- On 5/14/2018 Jay S Skyler, Director, sold 30,000 with an average share price of $88.00 per share and the total transaction amounting to $2,640,000.00.
- On 5/9/2018 Kevin R Sayer, CEO, sold 17,245 with an average share price of $84.37 per share and the total transaction amounting to $1,454,960.65.
- On 5/8/2018 Jacob Steven Leach, SVP, sold 1,923 with an average share price of $84.95 per share and the total transaction amounting to $163,358.85.
- On 5/8/2018 Jay S Skyler, Director, sold 31,464 with an average share price of $85.11 per share and the total transaction amounting to $2,677,901.04.
- On 4/23/2018 Richard Doubleday, EVP, sold 2,581 with an average share price of $73.09 per share and the total transaction amounting to $188,645.29.
Recent Trading Activity for NASDAQ:DXCM – Dexcom (NASDAQ:DXCM)
Shares of NASDAQ:DXCM – Dexcom closed the previous trading session at 92.35 up +2.86 3.20% with 91.75 shares trading hands.